IVDR 2022: The Year In Review Webinar with IVD Insider Carlos Galamba Is the In Vitro Diagnostic Regulation (IVDR) wearing you down? If so, you’re...
Continue Reading11 Top Innovators in Real-World Evidence to Follow in 2023
By
Sean Smith on December 8, 2022
Huma.AI Is Among PharmStars Fall 2022 Graduates Today PharmStars, the pharma-focused accelerator for digital health startups, announced the...
Continue ReadingIVDR Insider Explains 5 Critical Impacts of the EU Clinical Evidence Requirements
By
Sean Smith on October 7, 2022
We recently published an exclusive MedTech Intelligence interview with Carlos Galamba, Vice President, Intelligence and Innovation with RQM+. Galamba...
Continue ReadingThe Elephant in the Room: RAPS LIVE Discussion on Developing a Sustainable Approach to IVDR Post-Market Compliance
By
Sean Smith on April 8, 2022
Huma.AI Co-Founder Lana Feng, Ph.D., to Present at RAPS Convergence 2022 Huma.AI is pleased to announce that Lana Feng, Ph.D. CEO and Co-Founder of...
Continue ReadingHuma.AI MDR and IVDR Expert Panel Discussion Highlighted the Need for New Machine Learning Solutions to Tackle Post-Market Data
By
Sean Smith on April 4, 2022
Last week, Huma.AI sponsored a webinar with MedTech Intelligence covering the challenges and opportunities created for post-market intelligence by EU...
Continue Reading